BeStock  
Markets › Compare › PLSE vs MMED

PLSE vs MMED

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
PLSE · Pulse Biosciences$45.55 ▲ 2.57%
MMED · MiniMed Group$16.01 ▼ 1.54%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

43116190263336Mar 6, '26Jul 16, '26Nov 20, '26
  • PLSE +151.1%
  • MMED -13.4%

Head to head

MetricPLSEMMED
Price$45.55$16.01
Change today▲ 2.57%▼ 1.54%
Market cap$3.35B$4.50B
Return, 3 months-7.3%-19.7%
Return, year to date+231.8%–
Return, 1 year+250.1%–
P/E (TTM)––
P/B18.21.2
P/E percentile vs own 5y4th34th
Dividend yield––
Revenue growth (YoY, latest qtr)+359.3%+16.6%
Net profit growth (YoY)-18.9%+100.0%
Gross margin26.8%53.9%
Operating margin-5,821.1%-5.0%
Net margin-5,603.9%-9.7%
Return on equity-60.6%-8.7%
Analyst target vs. price+46.4%+65.0%
Analyst buy share100%85%
RSI (14)4137
30-day volatility76.9%64.9%
Max drawdown, 1 year-29.5%-41.6%
Trend readLeaning bearishStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • MMED is the largest of the group by market value.
  • PLSE is growing revenue fastest.
  • MMED keeps the most profit per dollar of sales.
  • MMED has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top